Effects of Resistance Training Preconditioning on Skeletal Muscle Recovery From a Period of Disuse in Young Adults

Atrophy, Muscular Clinical Trial

Official title:

Effects of Resistance Training Preconditioning on Skeletal Muscle Recovery From a Period of Disuse in Young Adults

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05760066
• Other study ID #: MDR0823
• Status: Not yet recruiting
• Phase: N/A
• Start date: August 1, 2023
• Est. completion date: August 1, 2024

Study information

• Verified date: February 2023
• Source: Auburn University
• Contact: Michael D Roberts, PhD
• Phone: 334-844-1925
• Email: mdr0024[@]auburn.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the effects of resistance training (RT) preconditioning vs no training on disuse-induced atrophy and post-disuse resistance training in young healthy individuals. The main questions it aims to answer are:

• To determine if performing RT prior to a period of disuse enhances the regain of strength, skeletal muscle size, and skeletal muscle quality while performing RT after a period of disuse.

• To determine if performing RT prior to a period of disuse dampens the maladaptive effects of disuse on muscle size, muscle quality, and strength.

• To determine the anabolic and proteolytic mechanisms underpinning the observed outcomes.

Participants will:

1. Perform either 6 weeks of resistance training or maintain an untrained lifestyle

2. Perform 2 weeks of limb immobilization induced disuse of a randomized leg

3. Perform 6 weeks of resistance training

Researchers will compare the resistance training preconditioning condition vs the non-trained condition to see if resistance training prior to a period of disuse is beneficial during the disuse period and in the return to training period on skeletal muscle size, strength, and underpinning molecular markers.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 24
• Est. completion date: August 1, 2024
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Between the ages of 18-30

• Free from medical implants in lower extremity that would interfere with low-dose radiation

• Are not allergic to ultrasound gel or Lidocaine

• Have no or minimal experience with resistance training (less than 1 training session/week for a 1 year period)

Exclusion Criteria:

• Have been exposed to medically necessary radiation in the past 12 months other than dental x-rays

• Have known overt cardiovascular or metabolic disease

• Have a medical condition that would contraindicate participating in an exercise program or donating a skeletal muscle biopsy (e.g. blood clotting disorder, taking blood thinners, etc.)

• Are undergoing medical treatment for a disease that would interfere physiologically or logistically with study outcomes and/or protocols (e.g. undergoing chemotherapy and/or radiation for cancer treatment)

• Have consumed supplemental protein, creatine, and/or agents that affect hormone status (e.g. testosterone, growth hormone boosters, etc.) within the previous 2 months.

Related Conditions & MeSH terms

• Atrophy
• Atrophy, Disuse
• Atrophy, Muscular
• Muscular Atrophy
• Muscular Disorders, Atrophic

Intervention

Other:
• Resistance Training Preconditioning
Resistance training prior to disuse-induced atrophy followed by another period of resistance training
• Control
Activities of daily living prior to disuse-induced atrophy followed by a period of resistance training

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Auburn University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in vastus lateralis fiber cross-sectional area	Upon the procurement and analysis of muscle from the vastus lateralis of participants, histological techniques will be used to assess fiber cross-sectional area of muscle fibers	Through completion of study, 16 weeks
Primary	Change in quadriceps strength via 3 repetition maximum testing	Strength of the quadriceps will be assessed via 3-repetition maximum testing of select exercises (leg press, leg extension, hex-bar deadlift)	Through completion of study, 16 weeks
Primary	Change in quadriceps strength via isokinetic dynamometry	Strength of the quadriceps will be assessed via isokinetic dynamometry	Through completion of study, 16 weeks
Secondary	Change in protein expression of anabolic signaling proteins	Western blotting will be performed and quantified in relative fluorescence units for proteins involved in the mechanistic target of rapamycin signaling pathway.	Through completion of study, 16 weeks
Secondary	Change in protein expression of catabolic signaling proteins	Western blotting will be performed and quantified in relative fluorescence units for proteins involved in the catabolic signaling pathways (e.g. ubiquitin-proteasome system, calpain system, autophagy).	Through completion of study, 16 weeks
Secondary	Change in activity of catabolic systems	Activity assays will be performed and quantified in relative fluorescence units normalized to muscle soluble protein abundance in order to quantify the activity of the calpain system and the 20S proteasome core.	Through completion of study, 16 weeks
Secondary	Gene expression at the mRNA level of atrophy-associated genes (atrogenes)	Real time quantitative polymerase chain reactions (qPCR) will be used to quantify the expression of select genes associated with atrophy. These data will be reported as fold-change from baseline and will be normalized to one or more housekeeping genes whose value does not change throughout the duration of the study.	Through completion of study, 16 weeks